IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
about
Pediatric Acute Respiratory Distress Syndrome: Fibrosis versus RepairRNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal diseaseIntranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune responseIntranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaquesAbsence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection.Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin K.Gene therapy for ALI/ARDS.Gene and cell therapy based treatment strategies for inflammatory bowel diseases.Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repairAcute respiratory distress syndrome: new definition, current and future therapeutic optionsImmunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation.Suppression of transforming growth factor β1 in lung alveolar epithelium-derived cells using adeno-associated virus type 2/5 vectors to carry short hairpin RNA.Development and validation of a multiplex microsphere-based assay for detection of domestic cat (Felis catus) cytokines.Acute lung injury induced by whole gastric fluid: hepatic acute phase response contributes to increase lung antiprotease protection.Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis.Modulating inflammation in a cutaneous chronic wound model by IL-10 released from collagen-silica nanocomposites via gene delivery.Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia.Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia.
P2860
Q26749366-785B2345-9750-49C2-86CD-F5F9703F0253Q34663536-6F763628-CA16-4C04-A738-D148C1C71DA7Q35568518-0FCB4DB2-56AE-4156-8684-13C44DA0B350Q36114234-AF5D4949-8B19-4E62-BC27-BA42973ACA9CQ36332718-05F9C664-6001-4F6B-903E-6639C227DB0AQ36534907-6EC29021-D000-49A6-A027-38280113F51BQ37899551-389B7920-F841-4130-B818-6A9D5E3FD249Q37969759-163D4B63-EDDB-46CB-B98B-1C53D72E49DCQ38008342-E9AB06C8-BE8E-4484-B01F-6E39A7CA9747Q38119218-BDA611C2-3DB1-4260-9D8E-AFE569C5DD79Q39001670-93C6E811-E6B9-40FC-8BC9-14D0C2E21FE1Q39602375-DC0884DA-C76A-4756-9FAA-0A583DC15D53Q41862460-CE794C66-340B-45AD-AE4E-9B11BB93B44AQ41952253-D6437A86-0E91-4581-A838-DCCF33F5FAF5Q42120838-C7F342E8-1E75-48A3-9CB8-BE2B5D026213Q48536078-A6E83AB0-01D9-4AC2-AB5B-3DEB697137DDQ51701788-6D4A0F97-38A8-4167-89B9-EF870D3073C4Q54390257-0C424305-5DF4-4129-85EE-5E63183FC861
P2860
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
@en
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
@nl
type
label
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
@en
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
@nl
prefLabel
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
@en
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
@nl
P2093
P2860
P356
P1433
P1476
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
@en
P2093
I L Virella-Lowell
J N McCall
S M Caldwell
T R Flotte
T W Ferkol
P2860
P2888
P304
P356
10.1038/GT.2010.28
P577
2010-04-01T00:00:00Z
P5875
P6179
1013553504